Jakob Dupont - 22 Sep 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Jakob Dupont
Issuer symbol
PYXS
Transactions as of
22 Sep 2023
Net transactions value
$0
Form type
4
Filing time
26 Sep 2023, 19:04:57 UTC
Previous filing
25 Aug 2023
Next filing
28 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PYXS Stock Option (Right to Buy) Award $0 +392,461 $0.000000 392,461 22 Sep 2023 Common Stock 392,461 $1.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in three equal annual installments beginning on the first anniversary of August 23, 2023, subject to the reporting person's continued service through the applicable vesting date.